JAKARTA - Vice President Ma'ruf Amin will not be injected with the COVID-19 vaccine made by Sinovac during the first phase of simultaneous vaccination in Indonesia.
"Because the Vice President is over 60 years old, it is not possible for him to be vaccinated with the current vaccine, the Sinovac one," Masduki was quoted as saying by Antara, Tuesday, January 5.
Vice President Ma'ruf will receive a vaccine that matches the criteria for his age and health condition.
"Maybe later in the next stage, if there is a vaccine that fits the criteria of the Vice President's condition," he said.
The COVID-19 vaccine that is currently available in Indonesia is made by Sinovac and is currently undergoing clinical trials to obtain an emergency use authorization (UEA) by the Food and Drug Supervisory Agency (BPOM) as well as a halal fatwa from the Indonesian Ulema Council (MUI) .
Based on recommendations from the Indonesian Internal Medicine Specialist Association (PAPDI), recipients of the COVID-19 vaccine must be in the age range of 18 to 59 years.
In addition, vaccine recipients must not suffer from comorbid diseases, including systemic autoimmunity, acute infections, chronic kidney disorders, hypertension, coronary heart problems, hypothyroidism, and cancer.
Meanwhile, President Joko Widodo will be the first recipient of the vaccine made by Sinovac in Indonesia, which is scheduled for Wednesday, January 13.
The COVID-19 vaccine made by Sinovac has arrived in Indonesia as many as 3 million doses, which were sent in two stages, namely 1.2 million doses on December 6, 2020 and 1.8 million doses on December 31, 2020.
To date, the Sinovac vaccine has been distributed and arrived in Banten (14,560 doses), Central Java (62,560 doses), Jambi (20,000 doses), West Sumatra (36,920 doses), South Sumatra (30,000 doses), Bengkulu (20,280 doses) , North Kalimantan (10,680 doses), West Sulawesi (5,960 doses), and Papua (14,680 doses).
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
